Ontology highlight
ABSTRACT:
SUBMITTER: Xue C
PROVIDER: S-EPMC10517553 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature
Xue Cheng C Wang Jian J Pan Jinyan J Liang Congdie C Zhou Chenchen C Wu Jun J Song Shuwei S Cui Linlin L Zhang Liming L Liu Yawei Y Dai Bing B
BMC nephrology 20230922 1
Rituximab (RTX) and cyclophosphamide (CYC) based treatments are both recommended as first-line therapies in idiopathic membranous nephropathy (IMN) by KDIGO 2021 guideline. However, the efficacy of RTX vs. CYC-based treatments in IMN is still controversial. We performed this systemic review and meta-analysis registered in PROSPERO (CRD 42,022,355,717) by pooling data from randomized controlled trials or cohort studies in IMN patients using the EMBASE, PubMed, and Cochrane libraries (till Orc 1, ...[more]